This list is an analysis based on recent market events. It's not an investment recommendation.
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
FAQs
What is Drugs Made In America Acquisition II stock price today?▼
The current price of DMII is $10.20 USD — it has increased by +0% in the past 24 hours. Watch Drugs Made In America Acquisition II stock price performance more closely on the chart.
What is Drugs Made In America Acquisition II stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Drugs Made In America Acquisition II stocks are traded under the ticker DMII.
What is Drugs Made In America Acquisition II market cap?▼
Today Drugs Made In America Acquisition II has the market capitalization of 649.74M
What is Drugs Made In America Acquisition II revenue for the last year?▼
Drugs Made In America Acquisition II revenue for the last year amounts to 0 USD.
What is Drugs Made In America Acquisition II net income for the last year?▼
DMII net income for the last year is 4.13M USD.
How many employees does Drugs Made In America Acquisition II have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Drugs Made In America Acquisition II located?▼
Drugs Made In America Acquisition II operates in the Finance & Payments sector.
When did Drugs Made In America Acquisition II complete a stock split?▼
Drugs Made In America Acquisition II has not had any recent stock splits.
Where is Drugs Made In America Acquisition II headquartered?▼
Drugs Made In America Acquisition II is headquartered in NEW YORK, Cayman Islands.